Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.054 | 0.7 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |